General Inception announces the launch of Igniter Europe, focused on building innovative companies in the field of oncology, autoimmune and rare diseases, with novel therapeutics and disruptive technology platforms that enable accelerated drug development with data analytics solutions leveraging patients’ data and clinical insights early on in the phase of drug development.